http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210011273-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3e6d8f05d9475eab2cebb5c85f9f80 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1081 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate | 2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4f7d099e840853384d13d4109741c9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af119b5b4d28a1994893b9dd9988b9d6 |
| publicationDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210011273-A |
| titleOfInvention | Monoclonal antibody with specificity for the envelope protein domain Ⅲ of Zika virus, hybridoma cell line producing the same and use thereof |
| abstract | The present invention provides a monoclonal antibody specifically binding to the'Zika virus envelope protein domain III'; A hybridoma cell line that produces the monoclonal antibody; A composition for diagnosing infection of Zika virus, including the monoclonal antibody; It relates to a kit for diagnosing Zika virus infection and a method for diagnosing Zika virus infection comprising the monoclonal antibody. The monoclonal antibody produced from the hybridoma cells of the present invention has a specific high binding affinity only for'Zika virus coat protein domain III', but at the same time does not react with the coat protein of another virus, such a monoclonal antibody The antibody can be usefully used for detecting Zika virus or diagnosing Zika virus infection. In addition, the monoclonal antibody produced from the hybridoma cells of the present invention using these characteristics is the development of technologies related to the observation of the treatment prognosis of Zika virus infection, the detection and quantitative analysis of the Zika virus or the envelope protein domain III of Zika virus. It can also be used usefully. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102021102523-A1 |
| priorityDate | 2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1119.